← Evidence map

ArticleCase reports in oncology

Long-Term Continuation Therapy with Nab-Paclitaxel and Bevacizumab ± Anti-PD-1 in Advanced Non-Small Cell Lung Cancer: Case Reports and Mechanistic Insights.

Xiaofen Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Long-Term Continuation Therapy with Nab-Paclitaxel and Bevacizumab ± Anti-PD-1 in Advanced Non-Small Cell Lung Cancer: Case Reports and Mechanistic Insights. | OpenQuestion